Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases
Stopped Project Never Initiated since sponsor stopped support for the trial- no human subjects were enrolled and no data regarding humans was collected or studied
Conditions
- Brain Metastases from Non-small Cell Lung Cancer
Interventions
- RADIATION: Stereotactic Radiation Therapy
- DRUG: Durvalumab
Sponsor
University of Texas Southwestern Medical Center